We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Benign Hematology

Journal Scan / Research · October 13, 2020

Effectiveness and Safety of Apixaban and Rivaroxaban for Acute VTE Therapy in Patients With Extremes in Body Weight

European journal of haematology

 

Additional Info

European journal of haematology
Effectiveness and Safety of Apixaban and Rivaroxaban for Acute Venous Thromboembolism Therapy in Patients With Extremes in Body Weight
Eur. J. Haematol. 2020 Jun 17;[EPub Ahead of Print], WE Wysokinski, DA Froehling, DE Houghton, RD McBane, DT Vlazny, DM Bott-Kitslaar, W Kuczmik, K Sutkowska, K Bator, DO Hodge, LG Peterson, AI Casanegra

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading